Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CMV Infection After Allogenic HSCT”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Not applicableStudy completedNCT03910478
What this trial is testing

Dried Blood Spot Testing of CMV Detection in HCT Recipients

Who this might be right for
Cytomegalovirus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 622
Testing effectiveness (Phase 2)Study completedNCT01646645
What this trial is testing

Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegalovirus
Memorial Sloan Kettering Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT00223925
What this trial is testing

Maribavir for Prevention of CMV After Stem Cell Transplants

Who this might be right for
Cytomegalovirus Infection
Shire 111
Large-scale testing (Phase 3)Study completedNCT01077908
What this trial is testing

Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study

Who this might be right for
Cytomegalovirus Infection
Cell Medica Ltd 89
Early research (Phase 1)UnknownNCT05140187
What this trial is testing

CMV-TCR-T Cells for CMV Infection After Allogenic HSCT

Who this might be right for
CMV Infection After Allogenic HSCT
Chinese PLA General Hospital 12
Early research (Phase 1)UnknownNCT02456610
What this trial is testing

Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in China

Who this might be right for
Viral Infection
Affiliated Hospital to Academy of Military Medical Sciences 30
Not applicableStudy completedNCT05315882
What this trial is testing

Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis >> GVHD PROPHYLAXIS ERA

Who this might be right for
CMV Infection
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 300
Testing effectiveness (Phase 2)Ended earlyNCT03343600
What this trial is testing

Imatinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Patients Who Have Received Allo-HSCT
National Taiwan University Hospital 5
Testing effectiveness (Phase 2)Study completedNCT05471661
What this trial is testing

T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation

Who this might be right for
Opportunistic Fungal InfectionOpportunistic Viral InfectionBone Marrow Transplant Infection
George Papanicolaou Hospital 10
Not applicableNot Yet RecruitingNCT07210242
What this trial is testing

HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCR

Who this might be right for
Cytomegalovirus InfectionsHematopoietic Stem Cell TransplantationVirus Reactivation+1 more
Ting YANG 300
Testing effectiveness (Phase 2)Study completedNCT03940586
What this trial is testing

Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)

Who this might be right for
Cytomegalovirus (CMV) Infection
Merck Sharp & Dohme LLC 65
Early research (Phase 1)Looking for participantsNCT04013802
What this trial is testing

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Who this might be right for
Viral Infection
Baylor College of Medicine 47
Very early researchLooking for participantsNCT03665675
What this trial is testing

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientCytomegalovirusDonor+2 more
Sumithira Vasu 20
Large-scale testing (Phase 3)Study completedNCT00016068
What this trial is testing

Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation

Who this might be right for
Infection
Fred Hutchinson Cancer Center 184
Early research (Phase 1)Study completedNCT01070797
What this trial is testing

Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)

Who this might be right for
Adenovirus InfectionEpstein-Barr Virus InfectionsCytomegalovirus Infections+1 more
Baylor College of Medicine 10
Not applicableStudy completedNCT04478474
What this trial is testing

Cytomegalovirus (CMV) Viremia and Disease Occurrence in Pediatric Allogeneic Stem Cell Transplantation Recipients

Who this might be right for
Cytomegalovirus Infections
New York Medical College 100
Testing effectiveness (Phase 2)Study completedNCT02227641
What this trial is testing

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Patients Undergoing Allogeneic Stem Cell Transplantation
University of Erlangen-Nürnberg Medical School 50
Not applicableUnknownNCT04051372
What this trial is testing

Diagnosis of Lung Complication After Allo-HSCT by Multiple Parameter System Through BAL

Who this might be right for
Bronchoalveolar Lavage FluidLung Infection
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 250
Early research (Phase 1)Study completedNCT02313857
What this trial is testing

Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)

Who this might be right for
CMV Infections
AlloVir 10
Testing effectiveness (Phase 2)Ended earlyNCT05370976
What this trial is testing

Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation.

Who this might be right for
Cytomegalovirus Infections
University Hospital, Lille 2
Next Page